Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
The vial should be discarded immediately
The funding source had no role in the design, conduct of the study, collection, management, analysis and interpretation or preparation, review, or approval of the manuscript
Yes (strong) FDA status FDA-approved (T2D and obesity) Compound NAD+ (intravenous or subcutaneous) Mechanism Direct NAD+ supplementation Route IV infusion or subcutaneous Acts on appetite
In this B12 article, I am focusing on the vitamin itself, because it deserves dedicated treatment given how commonly it is deficient in post-weight-loss patients and how significant the consequences of that deficiency can be
Duan X, Kong Z, Mai X, Lan Y, Liu Y, Yang Z, Zhao Z, Deng T, Zeng T, Cai C, Li S, Zhong W, Wu W, Zeng G (2018) Autophagy Inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
)
